Status:
WITHDRAWN
Impact of COVID-19 on the Incidence, Characteristics, Management and Outcome of Sepsis
Lead Sponsor:
National Institutes of Health Clinical Center (CC)
Collaborating Sponsors:
Emory University
Conditions:
Sepsis
Septic Shock
Eligibility:
All Genders
Brief Summary
This study seeks to determine the the impact of COVID-19 on the incidence, characteristics, management and outcome of patients admitted to U.S. hospitals with non-COVID-19 related sepsis.
Detailed Description
Sepsis is the most common cause of death and the most expensive condition among hospitalized patients in the U.S. The delivery of high-quality care for sepsis necessitates optimal institutional functi...
Eligibility Criteria
Inclusion
- Patients admitted to U.S hospitals with sepsis (without COVID-19)
- Patients admitted to U.S hospitals with acute gastrointestinal bleeding (without COVID-19 or sepsis)
- Patients admitted to U.S hospitals with sepsis myocardial infarction (without COVID-19 or sepsis)
Exclusion
- Patients admitted to U.S. hospitals with COVID-19
- Patients with acute gastrointestinal bleeding with sepsis or COVID-19
- Patients with myocardial infarction with sepsis or COVID-19
Key Trial Info
Start Date :
August 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04698382
Start Date
August 1 2020
End Date
December 31 2023
Last Update
March 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892